Another study discovered that PAD2 can regulate gene expression and profileration of breast cancer cells via its ability to target an arginine residue in the C-terminal domain of RNA polymerase II (RNAP2), which facilitates the interaction between RNAP2 and the positive transcription elongation factor b (P-TEFb) complex [85]. Here, PADI2 is linked to breast cancer.